Prognostic role of immune environment in luminal B early breast cancer

Prognostic role of immune environment in luminal B early breast cancer

Abstract The importance of the immune microenvironment in triple negative and HER2‐amplified breast cancer (BC) is well‐established; less is known about the immune environment in luminal breast cancers. We aimed to assess for the impact of immune biomarkers on BC outcome in a group of luminal B pati...

Full description

Bibliographic Details
Main Authors:	Arlene Chan, Jespal Gill, HuiJun Chih, Delia J. Nelson
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	Cancer Medicine
Subjects:	anti‐cancer immunity checkpoint molecules luminal B breast cancer predictive prognostic
Online Access:	https://doi.org/10.1002/cam4.5642

Similar Items

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
by: Antonino Grassadonia, et al.
Published: (2021-07-01)

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
by: Atif Ali Hashmi, et al.
Published: (2018-01-01)

The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer
by: Xin An, et al.
Published: (2018-03-01)

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
by: Kalhara R. Menikdiwela, et al.
Published: (2022-11-01)

Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age
by: Runnak A Majid, et al.
Published: (2017-04-01)

ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis
by: Yu Xiao, et al.
Published: (2022-05-01)

Platelet Concentration and Platelet/Lymphocyte Ratio as Prognostic Indicators in Luminal Breast Cancer
by: Angela Della’Santa Rubio O. Rönnau, et al.
Published: (2023-01-01)

Opportunities, obstacles and current challenges of flavonoids for luminal and triple-negative breast cancer therapy
by: Vanina S. Vachetta, et al.
Published: (2022-12-01)

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
by: Bin Xiao, et al.
Published: (2018-04-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
by: Dorsay Sadeghian, et al.
Published: (2022-02-01)

Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
by: Yong Hwa Eom, et al.
Published: (2023-03-01)

Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
by: Maria Amorim, et al.
Published: (2019-09-01)

Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity
by: Stefan Prekovic, et al.
Published: (2023-12-01)

Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results
by: Aurelia Noske, et al.
Published: (2020-02-01)

Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis
by: An Xu, et al.
Published: (2023-05-01)

Histopathological Patterns and Luminal Subtypes among Breast Cancer Patients in the Middle Euphrates Region of Iraq
by: Ahmed Mjali, et al.
Published: (2022-08-01)

The experience of preoperative treatment with anthracyclines in patients with luminal-type B locally advanced breast cancer
by: D. Ye. Cherniavskyi, et al.
Published: (2022-09-01)

Evaluation of the potential role of long non-coding RNA LINC00961 in luminal breast cancer: a case–control and systems biology study
by: Sepideh Mehrpour Layeghi, et al.
Published: (2020-10-01)

The Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and Metastasis
by: Arwa Flemban, et al.
Published: (2015-09-01)

Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
by: Jiangfeng Wu, et al.
Published: (2022-11-01)

GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer
by: Zi Wang, et al.
Published: (2023-01-01)

Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis
by: Rong Jia, et al.
Published: (2020-10-01)

“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
by: Höller A, et al.
Published: (2023-07-01)

Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
by: Ting Huang, et al.
Published: (2023-04-01)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
by: Motyka J, et al.
Published: (2023-07-01)

Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution
by: Heying Xie, et al.
Published: (2023-01-01)

Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
by: Yanyan Wang, et al.
Published: (2020-11-01)

LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer
by: Marco Antonio Fonseca-Montaño, et al.
Published: (2023-05-01)

Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
by: Anna Diana, et al.
Published: (2022-03-01)

Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer Patients
by: Yiwei Tong, et al.
Published: (2022-05-01)

Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer
by: Nguyen Xuan Thang, et al.
Published: (2022-03-01)

Validation of Online Prognostication Model that Predicts Survival for Women with Early Breast Cancer in Egypt
by: Gehan A. Khedr, et al.
Published: (2020-12-01)

FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
by: Jasna Metovic, et al.
Published: (2022-09-01)

GRHL2-controlled gene expression networks in luminal breast cancer
by: Zi Wang, et al.
Published: (2023-01-01)

The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score
by: Zheng‐Jun Yang, et al.
Published: (2023-02-01)

Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
by: Qiaorui Tan, et al.
Published: (2022-04-01)

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
by: Maria Barton, et al.
Published: (2019-10-01)

Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland
by: Yuliya A. Veryaskina, et al.
Published: (2020-05-01)

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
by: Miriam Ragle Aure, et al.
Published: (2017-03-01)

The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
by: Udo Jeschke, et al.
Published: (2019-02-01)